Postmenopausal high-gonadotropin-releasing hormone environment mediates pancreatic β-cell compensation via the cAMP-PKA-PDX1 pathway
World Journal of Diabetes · 2026-11-15 · 17 (11)
DOI: 10.4239/wjd.121630 ↗Abstract
BACKGROUND Menopause increases the risk of type 2 diabetes, which is typically attributed to estrogen deficiency; however, the metabolic impact of the concurrent postmenopausal surge in gonadotropin-releasing hormone (GnRH) remains undefined. AIM To investigate the direct regulatory role of GnRH in β-cell function. METHODS We assessed β-cell-specific GnRH receptor (GnRHR) expression in murine islets. The GnRH agonist gonadorelin was used to evaluate insulin secretion and downstream signaling pathways. Pharmacological and genetic manipulation approaches were applied to verify involvement of the cAMP-PKA-CREB1-PDX1 signaling cascade. In vivo , ovariectomized mice were used to model a high-endogenous GnRH environment, and db/db mice were used to assess responses under chronic metabolic stress. RESULTS GnRHR was expressed in murine β-cells. Gonadorelin increased insulin secretion via activation of the cAMP-PKA-CREB1-PDX1 signaling cascade, as confirmed by pharmacological and genetic interventions. In ovariectomized mice, elevated endogenous GnRH promoted compensatory β-cell expansion and hyperinsulinemia, thereby mitigating metabolic impairment. In db/db mice, chronic metabolic stress led to concurrent downregulation of GnRHR and insulin expression, although the GnRHR signaling axis remained responsive to stimulation. CONCLUSION GnRHR signaling contributes to pancreatic β-cell compensation through cAMP-dependent signaling, while this response appears limited by advanced β-cell structural deterioration.
EUVIMED